SEC 13F Intelligence

Capital Research Global Investors / TMO

Capital Research Global Investors’s Thermo Fisher Scientific Inc Position

Does Capital Research Global Investors own Thermo Fisher Scientific Inc (TMO)? Yes — 4.41M shares worth $2.2B (+0.34% of its 13F portfolio) as of Q1 2026, up from 2.91M shares the prior filed quarter.

Position Value
$2.2B
Q1 2026
Shares
4.41M
% of Portfolio
+0.34%
Quarters Held
30
currently held

Position History TMO

Reported value by quarter
Q4 ’18: $3.6BQ4 ’18Q1 ’19: $4.0BQ2 ’19: $3.8BQ3 ’19: $3.5BQ4 ’19: $3.8BQ4 ’19Q1 ’20: $3.3BQ2 ’20: $4.2BQ3 ’20: $5.1BQ4 ’20: $4.6BQ4 ’20Q1 ’21: $4.0BQ2 ’21: $4.6BQ3 ’21: $5.3BQ4 ’21: $6.3BQ4 ’21Q1 ’22: $5.1BQ2 ’22: $4.8BQ3 ’22: $4.4BQ4 ’22: $3.9BQ4 ’22Q1 ’23: $3.4BQ2 ’23: $3.2BQ3 ’23: $3.8BQ4 ’23: $4.2BQ4 ’23Q1 ’24: $4.7BQ2 ’24: $4.6BQ3 ’24: $5.1BQ4 ’24: $4.1BQ4 ’24Q1 ’25: $3.8BQ2 ’25: $2.2BQ3 ’25: $1.5BQ4 ’25: $1.7BQ4 ’25Q1 ’26: $2.2Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20264.41M$2.2B+0.34%
Q4 20252.91M$1.7B+0.31%
Q3 20253.16M$1.5B+0.29%
Q2 20255.43M$2.2B+0.44%
Q1 20257.61M$3.8B+0.82%
Q4 20247.92M$4.1B+0.85%
Q3 20248.19M$5.1B+1.05%
Q2 20248.24M$4.6B+1.00%
Q1 20248.11M$4.7B+1.07%
Q4 20237.99M$4.2B+1.04%
Q3 20237.47M$3.8B+1.04%
Q2 20236.09M$3.2B+0.85%
Q1 20235.93M$3.4B+0.98%
Q4 20227.16M$3.9B+1.19%
Q3 20228.76M$4.4B+1.46%
Q2 20228.74M$4.8B+1.48%
Q1 20228.69M$5.1B+1.27%
Q4 20219.45M$6.3B+1.39%
Q3 20219.25M$5.3B+1.23%
Q2 20219.06M$4.6B+1.06%
Q1 20218.85M$4.0B+0.99%
Q4 20209.94M$4.6B+1.20%
Q3 202011.58M$5.1B+1.53%
Q2 202011.66M$4.2B+1.34%
Q1 202011.79M$3.3B+1.31%
Q4 201911.80M$3.8B+1.15%
Q3 201912.03M$3.5B+1.15%
Q2 201912.86M$3.8B+1.20%
Q1 201914.67M$4.0B+1.27%
Q4 201815.93M$3.6B+1.24%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Capital Research Global Investors’s full portfolio or all institutional holders of TMO.